Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine|DRUG: hormonal treatment (tamoxifen, exemestane, anastrozole or letrozole)
Sponsor: The Netherlands Cancer Institute